Growth inhibition and biodegradation of catecholamines in the ciliated protozoan Tetrahymena pyriformis

Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering

Volumn 43, Issue 14, 2008, Pages 1610-1617

  Ud Daula, Asad ^a   Pfister, Gerd ^a   Schramm, Karl Werner ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biogenic monoamines; Catecholamines; Growth inhibition; Metabolites; Tetrahymena pyriformis; Toxicity

Indexed keywords

BIOCHEMISTRY; BIODEGRADATION; BIOMOLECULES; BRAIN; CELL CULTURE; CELLS; CONCENTRATION (PROCESS); CYTOLOGY; HORMONES; METABOLITES; TOXICITY;

ACUTE TOXICITIES; BIOGENIC MONOAMINES; CATECHOLAMINES; CULTURE MEDIUMS; GROWTH INHIBITION; GROWTH INHIBITIONS; HIGHER CONCENTRATIONS; IN-VIVO; NORADRENALIN; OXIDIZING ENVIRONMENTS; PHYSIOLOGICAL CONCENTRATIONS; REVERSE PHASE; TETRAHYMENA; TETRAHYMENA PYRIFORMIS; TOXIC POTENTIALS; WELL PLATES;

AMINES;

CATECHOLAMINE; DOPAMINE; LEVODOPA; NORADRENALIN;

ACUTE TOXICITY; ARTICLE; BIODEGRADATION; CATECHOLAMINE METABOLISM; CATECHOLAMINE RELEASE; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; CULTURE MEDIUM; GROWTH INHIBITION; METABOLITE; NONHUMAN; TETRAHYMENA PYRIFORMIS;

ANIMALS; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; TETRAHYMENA PYRIFORMIS;

MYXOZOA; PROTISTA; TETRAHYMENA; TETRAHYMENA PYRIFORMIS;

EID: 55749101746     PISSN: 10934529     EISSN: 15324117     Source Type: Journal    
DOI: 10.1080/10934520802329885     Document Type: Article

References (23)

1. Smith, T.A. Phenylalanine and related compounds in the plants. Phytochem. 1977, 16, 9-18.
2. Szopa, J.; Wilczyński, G.; Fiehn, O.; Wenczel, A.; Willmitzer, L. Identification and quantification of catecholamines in potato plants (Solanum tuberosum) by GC-MS. Phytochem. 2001, 58, 315-320.
3. Rosenberg, P.A. Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci. 1988, 8(8), 2887-2894.
4. Stokes, A.H.; Hastings, T.G.; Vrana, K.E. Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 1999, 55, 659-665.
5. Cyr, M.; Beaulieu, J.M.; Laakso, A.; Sotnikova, T.D.; Yao, W.D.; Bohn, L.M.; Gainetdinov, R.R.; Caron, M.G. Sustained elevation of extra cellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc. Natl. Acad. Sci. 2003, 100, 11035-11040.
6. Stokes, A.H.; Lewis, D.Y.; Lash, L.H.; Jerome, W.G.; Grant, K.W.; Aschner, M.; Vrana, K.E. Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis. Brain Res. 2000, 858, 1-8.
7. Ben-Shachar, D.; Zuk, R.; Gazawi, H.; Ljubuncic, P. Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopaminerelated neuropsychiatric disorders. Biochem. Pharmacol. 2004, 67, 1965-1974.
8. Spina, M.B.; Cohen, G. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc. Natl. Acad. Sci. 1989, 86, 1398-1400.
9. Ole, T.; Bjorg, A.; Torgeir, F.; Andersso, K.K.; Morten, S. One-electron oxidation of catecholamines generates free radicals with an in vitro toxicity correlating with their lifetime. Free Rad. Biol. Med. 2006, 41, 1266-1271.
10. Le Roith, D.; Roth, J. Vertebarte hormones and neuropeptides in microbes: evolutionary origin of intracellular communication. Front Neuroendocrinol. 1985, 8, 1-25.
11. Brizzi, G.; Blum, J.J. Effect of growth conditions on serotonin content of Tetrahymena pyriformis. J. Protozool. 1970, 17, 553-555.
12. Goldman, M.E.; Gundersen, R.; Erickson, C.K.; Thompson, G.A. High-performance liquid chromatography analysis of catecholamines in growing and non-growing Tetrahymena. Biochem. Biophys. Acta 1981, 676, 221-225.
13. Gundersen, R.E.; Thompson, G.A. Jr. Factors influencing the pattern of dopamine secretion in Tetrahymena pyriformis. Biochem. Biophys. Acta 1983, 755, 186-194.
14. Naokuni, T.; Kanji, S. Metabolism of biogenic monoamines in the ciliated protozoan, Tetrahymena pyriformis. Comp. Biochem. Physiol. 1993, 106(1), 63-70.
15. Plesner. P.; Rasmussen, L; Zeuthen, E. Techniques used in the study of synchronous Tetrahymena. In: Zeuthen, E editor. Synchrony in cell division and growth. Interscience Publ: New York; 1964; 543-563.
16. Litchfield, J.T. Jr.; Wilcoxon, F. A simplified method of evaluating dose-effect experiment. J. Pharmacol. Exp. Ther. 1949, 96, 99-113.
17. Graham, D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 1978, 14, 633-643.
18. Graham, D.G.; Tiffany, S.M.; Bell, W.R. Jr.; Gutknecht, W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward c1300 neuroblastoma cells in vitro. Mol. Pharmacol. 1978, 14, 644-653.
19. Alan, H.; Stokes, T.G.; Hastings; Vrana, K.E. Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 1999, 55, 659-665.
20. Olano, C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 1993, 16(11), 439-444.
21. Pardo, B.; Mena, M.A.; De-Yebenes, J.G. L-DOPA inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells. J. Neurochem. 1995, 64(2), 576-582.
22. Donaldson, J.; McGregor, D.; LaBella, F. Manganese neurotoxicity: a model for free radical mediated neurodegeneration? Can. J. Physiol. Pharmacol. 1982, 60, 1398-1405.
23. 2 oxidation of dopamine. J. Med. Chem. 1995, 38, 917-922.